S. Attarian

发表

Region‐specific impairment of the cervical spinal cord (SC) in amyotrophic lateral sclerosis: A preliminary study using SC templates and quantitative MRI (diffusion tensor imaging/inhomogeneous magnetization transfer)

J. Ranjeva, M. Guye, V. Callot, 2017, NMR in biomedicine.

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

S. Solomon, M. Sweetser, Y. Parman, 2018, The New England journal of medicine.

ALS with respiratory onset: Clinical features and effects of non-invasive ventilation on the prognosis

J. Pouget, S. Attarian, A. Verschueren, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Clinical phenotype and outcome of hepatitis E virus–associated neuralgic amyotrophy

N. van Alfen, D. Benninger, B. V. van Engelen, 2017, Neurology.

Genetic Characterization of a French Cohort of GNE‐mutation negative inclusion body myopathy patients with exome sequencing

Svetlana Gorokhova, Jean-François Deleuze, Bruno Eymard, 2017, Muscle & nerve.

The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care

F. Rivier, F. Chapon, C. Richelme, 2019, Orphanet Journal of Rare Diseases.

Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy.

D. Figarella-Branger, N. Romero, J. Pouget, 2013, American journal of human genetics.

Internal modeling of upcoming speech: A causal role of the right posterior cerebellum in non-motor aspects of language production

Hanna S. Gauvin, M. Bonnard, R. Hartsuiker, 2016, Cortex.

Predicting Outcome in Guillain-Barré Syndrome

Hester F. Lingsma, G. Marfia, T. Feasby, 2021, Neurology.

Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial.

F. Bolgert, S. Chevret, B. Eymard, 2005, Archives of neurology.

Quantitative assessment of sciatic nerve changes in Charcot–Marie–Tooth type 1A patients using magnetic resonance neurography

Augustin C. Ogier, M. Guye, P. Viout, 2020, European journal of neurology.

A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A

P. van Damme, David John Adams, J. Statland, 2021, Orphanet Journal of Rare Diseases.

Guillain‐BarrÉ syndrome subtype diagnosis: A prospective multicentric European study

J. Raymackers, J. Woodard, J. Cassereau, 2018, Muscle & nerve.

Quantitative Brain Sodium MRI Depicts Corticospinal Impairment in Amyotrophic Lateral Sclerosis.

L. Schad, J. Ranjeva, S. Confort-Gouny, 2019, Radiology.

Skin Biopsy Findings in Patients With CMT1A: Baseline Data From the CLN-PXT3003-01 Study Provide New Insights Into the Pathophysiology of the Disorder

K. Nave, Serguei Nabirotchkin, Daniel Cohen, 2018, Journal of neuropathology and experimental neurology.

An overview of motor unit number index reproducibility in amyotrophic lateral sclerosis

F. Fatehi, S. Attarian, C. Neuwirth, 2019, Iranian journal of neurology.

Somatosensory evoked potentials in the assessment of peripheral neuropathies: Commented results of a survey among French-speaking practitioners and recommendations for practice

D. Guehl, O. Etard, P. Convers, 2015, Neurophysiologie Clinique/Clinical Neurophysiology.

Structural Connectivity Alterations in Amyotrophic Lateral Sclerosis: A Graph Theory Based Imaging Study

J. Ranjeva, M. Guye, B. Ridley, 2019, Front. Neurosci..

High rate of hypomorphic variants as the cause of inherited ataxia and related diseases: study of a cohort of 366 families

V. Fraix, L. Kremer, M. Koenig, 2021, Genetics in Medicine.

Clinical features and follow‐up of four new cases of facial‐onset sensory and motor neuronopathy

J. Pouget, P. Cintas, J. Azulay, 2011, Muscle & nerve.

Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

O. Blin, J. Hogrel, J. Pouget, 2009, The Lancet Neurology.

Disorders of motor neurons manifested by hyperactivity.

S. Attarian, A. Grapperon, 2017, Revue neurologique.

Hereditary neuropathy with liability to pressure palsies

D. Pareyson, F. Fatehi, S. Attarian, 2019, Journal of Neurology.

Long‐term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: Prospective analysis from the French Pompe Registry

F. Chapon, T. Perez, G. Bassez, 2020, Journal of inherited metabolic disease.

Full manuscript with supplementary data

Laura Bossi, Philippe Lehert, Serguei Nabirotchkin, 2015 .

Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network

Y. Péréon, P. Laforêt, T. Stojkovic, 2020, Revue Neurologique.

Analysis of the DYSF mutational spectrum in a large cohort of patients

C. Béroud, D. Figarella-Branger, F. Chapon, 2009, Human mutation.

Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values

John M Buermann, G. Marfia, H. Hartung, 2022, Clinical Neurophysiology.

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

M. Tarnopolsky, Y. Chien, J. Charrow, 2021, The Lancet Neurology.

Molecular combing reveals complex 4q35 rearrangements in Facioscapulohumeral dystrophy

F. Puppo, F. Magdinier, N. Lévy, 2017, Human mutation.

Patient-Reported Symptom Burden of Charcot–Marie–Tooth Disease Type 1A: Findings From an Observational Digital Lifestyle Study

R. Sivera, M. Larkin, G. Fabrizi, 2022, Journal of clinical neuromuscular disease.

The patient-reported impact of Charcot-Marie-Tooth disease in the real world: the design and conduct of a digital lifestyle study (CMT&Me)

M. Larkin, G. Fabrizi, S. Attarian, 2020 .

Acute motor and sensory axonal neuropathy and concomitant encephalopathy during tumor necrosis factor-alpha antagonist therapy

J. Pouget, J. Franques, A. M. Paula, 2010, Journal of the Neurological Sciences.

Response to treatment in patients with lewis–sumner syndrome

J. Pouget, E. Jouve, J. Franques, 2011, Muscle & nerve.

Multifocal motor neuropathy with and without conduction block

J. Pouget, J. Azulay, S. Attarian, 2006, Neurology.

Lewis–Sumner syndrome and multifocal motor neuropathy

J. Pouget, J. Azulay, S. Attarian, 2005, Muscle & nerve.

Neonatal lower motor neuron syndrome associated with maternal neuropathy with anti-GM1 IgG

J. Azulay, J. Pouget, B. Chabrol, 2004, Neurology.

Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera

L. Kremer, T. Maisonobe, A. Echaniz-Laguna, 2020, Journal of Neurology.

Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins

L. Kremer, David John Adams, T. Maisonobe, 2020, Clinical Neurophysiology.

Comparison of MRI and motor evoked potential with triple stimulation technique for the detection of brachial plexus abnormalities in multifocal motor neuropathy

A. Grapperon, S. Attarian, A. Verschueren, 2019, Muscle & nerve.

Relevance of anti-HNK1 antibodies in the management of anti-MAG neuropathies

J. Antoine, J. Camdessanché, A. Grapperon, 2019, Journal of Neurology.

Proximal conduction block in the pharyngeal–cervical–brachial variant of guillain–barrÉ syndrome

N. Yuki, Y. Duclos, J. Franques, 2015, Muscle & nerve.

Retrospective study of 75 children with peripheral inherited neuropathy: Genotype-phenotype correlations.

B. Chabrol, S. Attarian, F. Audic, 2018, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis

D. Annane, L. Kremer, T. Stojkovic, 2021, Neurology.

Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial

B. Byrne, A. Pestronk, M. Tarnopolsky, 2021, The Lancet Neurology.

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

G. L. Masson, D. Yarnitsky, S. Muley, 2018, The Lancet Neurology.

Magnetic stimulation using a triple‐stimulation technique in patients with multifocal neuropathy without conduction block

J. Pouget, J. Azulay, S. Attarian, 2005, Muscle & nerve.

Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: response to IVIg therapy

J. Pouget, J. Azulay, J. Franques, 2009, Journal of Neurology, Neurosurgery & Psychiatry.

Myofibrillar myopathies: State of the art, present and future challenges.

I. Nelson, D. Figarella-Branger, N. Romero, 2015, Revue neurologique.

Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies

J. Azulay, J. Pouget, J. Azulay, 2001, Clinical Neurophysiology.

Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation

J. Desvignes, N. Lévy, T. Stojkovic, 2018, BMJ Open.

Methylation hotspots evidenced by deep sequencing in patients with facioscapulohumeral dystrophy and mosaicism

F. Puppo, F. Magdinier, M. Bartoli, 2019, Neurology: Genetics.

An International Perspective on Preceding Infections in Guillain-Barré Syndrome

H. Hartung, T. Feasby, S. Kusunoki, 2022, Neurology.

Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS

A. Grapperon, S. Attarian, A. Verschueren, 2021, Scientific reports.

Monitoring the short-term effect of intravenous immunoglobulins in multifocal motor neuropathy using motor unit number index

A. Grapperon, S. Attarian, E. Delmont, 2017, Clinical Neurophysiology.

Triple‐stimulation technique in multifocal neuropathy with conduction block

J. Pouget, J. Azulay, S. Attarian, 2007, Muscle & nerve.

Motor unit number index (MUNIX) in patients with anti-MAG neuropathy

F. Fatehi, A. Grapperon, S. Attarian, 2017, Clinical Neurophysiology.

Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses

P. Latour, S. Attarian, D. Adams, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy

N. Yuki, J. Devaux, A. Berardinelli, 2017, Brain : a journal of neurology.

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

E. Nordh, Yi-Chung Lee, R. Sommerville, 2020, Lancet Neurology.

U1 snRNA mis-binding: a new cause of CMT1B

D. Bozon, P. Latour, P. Labauge, 2010, neurogenetics.

Charcot–Marie–Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study

T. Maisonobe, A. Echaniz-Laguna, P. Latour, 2021, European journal of neurology.

Genotype–phenotype correlation in French patients with myelin protein zero gene‐related inherited neuropathy

N. Lévy, A. Echaniz-Laguna, Y. Péréon, 2021, European journal of neurology.

MUSK, a new target for mutations causing congenital myasthenic syndrome.

C. Legay, L. Schaeffer, E. Goillot, 2004, Human molecular genetics.

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study

S. Kusunoki, L. Benedetti, C. Briani, 2021, Brain : a journal of neurology.

Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy

G. Kaplanski, J. Harlé, M. Ebbo, 2019, Clinical Rheumatology.

Iatrogenic immune-mediated neuropathies: diagnostic, epidemiological and mechanistic uncertainties for causality and implications for clinical practice

T. Kuntzer, H. S. Goedee, S. Attarian, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

Shoulder palsy following SARS‐CoV‐2 infection: two cases of typical Parsonage–Turner syndrome

S. Attarian, T. Le Corroller, E. Delmont, 2022, European journal of neurology.

Should we prevent thrombosis related to intravenous immunoglobulin infusions with systematic anticoagulant prophylaxis?

P. Suchon, S. Attarian, A. Verschueren, 2020, Revue neurologique.

Motor unit number index: A potential electrophysiological biomarker for pediatric spinal muscular atrophy

B. Chabrol, S. Attarian, E. Delmont, 2021, Muscle & nerve.

Transcranial magnetic stimulation (TMS): compared sensitivity of different motor response parameters in ALS.

J. Pouget, S. Attarian, S. Tréfouret, 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

A case of false positive cardiac troponin I in CANOMAD syndrome.

R. Guieu, T. Cuisset, S. Attarian, 2016, International journal of cardiology.

Detection of proximal conduction blocks using a triple stimulation technique improves the early diagnosis of Guillain–Barré syndrome

A. Grapperon, S. Attarian, E. Delmont, 2018, Clinical Neurophysiology.

Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European Survey.

K. Claeys, D. Pareyson, T. Mongini, 2022, Journal of neuromuscular diseases.

Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.

D. Figarella-Branger, G. Bassez, J. Pouget, 2007, Archives of neurology.

Wish to die and reasons for living among patients with amyotrophic lateral sclerosis

A. Loundou, A. Grapperon, S. Attarian, 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Chronic inflammatory demyelinating polyneuropathy and malignancy: A systematic review

S. Attarian, Y. Rajabally, 2018, Muscle & nerve.

Paraneoplastic subacute lower motor neuron syndrome associated with solid cancer

J. Honnorat, J. Pouget, S. Attarian, 2015, Journal of the Neurological Sciences.

Characteristics of patients with vitamin B12-responsive neuropathy: a case series with systematic repeated electrophysiological assessment

J. Pouget, L. Chiche, J. Franques, 2019, Neurological research.

Enteral and parenteral nutrition in the later stages of ALS: An observational study

J. Pouget, S. Attarian, A. Verschueren, 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy

S. Attarian, E. Delmont, Y. Rajabally, 2020, Journal of inflammation research.

The utility of motor unit number index: A systematic review

F. Fatehi, A. Grapperon, S. Attarian, 2018, Neurophysiologie Clinique.

265th ENMC International Workshop: Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22–24 April 2022, Hoofddorp, The Netherlands

N. Alfen, H. Kan, A. Pichiecchio, 2022, Neuromuscular Disorders.

Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15

E. Marchioni, L. Benedetti, J. Devaux, 2017, Journal of Neuroinflammation.

Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations*

I. Conceição, S. Attarian, M. Ueda, 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Development of a French isometric strength normative database for adults using quantitative muscle testing.

Claude Desnuelle, Arnaud Dupeyron, Lucette Lacomblez, 2007, Archives of physical medicine and rehabilitation.

Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease.

A. Laquérriere, G. Bassez, J. Pouget, 2016, Revue neurologique.

Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients

Thomas Robert, N. Jourde-Chiche, G. Habib, 2022, Clinical kidney journal.

Management challenges for chronic dysimmune neuropathies during the COVID‐19 pandemic

H. Hartung, H. S. Goedee, S. Attarian, 2020, Muscle & nerve.

Neurologic Disorders and Hepatitis E, France, 2010

R. Charrel, J. Pouget, P. Colson, 2011, Emerging infectious diseases.

Expanding the importance of HMERF titinopathy: new mutations and clinical aspects

K. Claeys, T. Stojkovic, W. Kress, 2019, Journal of Neurology.

Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers

F. Puppo, F. Magdinier, N. Lévy, 2014, Neurology.

Single‐fiber studies for assigning pathogenicity of eight mitochondrial DNA variants associated with mitochondrial diseases

J. Pouget, M. Soriani, A. Chaussenot, 2020, Human mutation.

Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy

S. Attarian, A. Verschueren, E. Delmont, 2020, Clinical Neurophysiology.

Identification of Variants in the 4q35 Gene FAT1 in Patients with a Facioscapulohumeral Dystrophy‐Like Phenotype

F. Puppo, Y. Hayashi, I. Nishino, 2015, Human mutation.

Deregulation of the Protocadherin Gene FAT1 Alters Muscle Shapes: Implications for the Pathogenesis of Facioscapulohumeral Dystrophy

F. Puppo, B. Herberth, F. Magdinier, 2013, PLoS genetics.

SMCHD1 is involved in de novo methylation of the DUX4-encoding D4Z4 macrosatellite

Shifeng Xue, F. Magdinier, B. Wollnik, 2019, Nucleic acids research.

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

R. Lewis, C. Sommer, B. Avau, 2021, Journal of the peripheral nervous system : JPNS.

Functional sparing of intrafusal muscle fibers in muscular dystrophies

E. Ribot-Ciscar, J. Roll, J. Aimonetti, 2005, Muscle & nerve.

R. Lewis, C. Sommer, B. Avau, 2021, European journal of neurology.

Regional variation of Guillain-Barré syndrome

G. Marfia, H. Hartung, S. Ajroud‐Driss, 2018, Brain : a journal of neurology.

Combined quantification of fatty infiltration, T1-relaxation times and T2*-relaxation times in normal-appearing skeletal muscle of controls and dystrophic patients

M. Guye, Y. Fur, O. Beuf, 2017, Magnetic Resonance Materials in Physics, Biology and Medicine.

Improving molecular diagnosis of distal myopathies by targeted next-generation sequencing

Christophe Béroud, Svetlana Gorokhova, Mathieu Cerino, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Low penetrance in facioscapulohumeral muscular dystrophy type 1 with large pathological D4Z4 alleles: a cross-sectional multicenter study

F. Magdinier, J. Pouget, N. Lévy, 2015, Orphanet Journal of Rare Diseases.

Impact of a frequent nearsplice SOD1 variant in amyotrophic lateral sclerosis: optimising SOD1 genetic screening for gene therapy opportunities

Y. Marie, V. Meininger, F. Salachas, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

Segregation between SMCHD1 mutation, D4Z4 hypomethylation and Facio-Scapulo-Humeral Dystrophy: a case report

F. Puppo, F. Magdinier, N. Lévy, 2016, BMC Medical Genetics.

Home‐based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy

D. Vissière, L. Servais, J. Vissing, 2022 .

Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial.

J. Hogrel, J. Pouget, P. Laforêt, 2009, Archives of physical medicine and rehabilitation.

Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study

Mark Bydder, David Bendahan, Maxime Guye, 2017, PloS one.

Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach.

F. Fatehi, S. Attarian, A. Le Troter, 2016, Revue neurologique.

Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1

David Bendahan, Badih Ghattas, Arnaud Le Troter, 2015, PloS one.

Type 1 FSHD with 6–10 Repeated Units: Factors Underlying Severity in Index Cases and Disease Penetrance in Their Relatives Attention

F. Magdinier, N. Lévy, A. Echaniz-Laguna, 2020, International journal of molecular sciences.

SMCHD1 is involved in de novo methylation of the DUX4-encoding D4Z4 macrosatellite

Shifeng Xue, F. Magdinier, Christopher, 2019, Nucleic acids research.

Molecular combing reveals allelic combinations in facioscapulohumeral dystrophy

J. Pouget, N. Lévy, A. Bensimon, 2011, Annals of neurology.

Novel CAPN3 variant associated with an autosomal dominant calpainopathy

M. Cossée, J. Pouget, N. Lévy, 2020, Neuropathology and applied neurobiology.

Deciphering the complexity of the 4q and 10q subtelomeres by molecular combing in healthy individuals and patients with facioscapulohumeral dystrophy

Albert David, Jon Andoni Urtizberea, Bruno Eymard, 2019, Journal of Medical Genetics.

Anti‐disialosyl‐immunoglobulin M chronic autoimmune neuropathies: a nationwide multicenter retrospective study

A. Echaniz-Laguna, Y. Péréon, P. Cintas, 2022, European journal of neurology.

Primary neurolymphomatosis diagnosis and treatment: A retrospective study

O. Chinot, J. Pouget, E. Tabouret, 2014, Journal of the Neurological Sciences.

Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy.

F. Magdinier, N. Lévy, H. Dufour, 2013, Human molecular genetics.

Predictive factors of efficacy of rituximab in patients with anti-MAG neuropathy

J. Pouget, J. Franques, S. Attarian, 2017, Journal of Neurological Sciences.

Determinants of health‐related quality of life in anti‐MAG neuropathy: a cross‐sectional multicentre European study

J. Cassereau, A. Grapperon, S. Attarian, 2017, Journal of the peripheral nervous system : JPNS.

Clinical spectrum and gender differences in a large cohort of Charcot–Marie–Tooth type 1A patients

O. Blin, J. Pouget, O. Dubourg, 2014, Journal of the Neurological Sciences.

HINT1 neuropathy: Expanding the genotype and phenotype spectrum

N. Lévy, P. Latour, T. Stojkovic, 2022, Clinical genetics.

A National French Consensus on Gene List for the Diagnosis of Charcot–Marie–Tooth Disease and Related Disorders Using Next-Generation Sequencing

M. Cossée, N. Lévy, P. Latour, 2022, Genes.

Transcranial magnetic stimulation in lower motor neuron diseases

J. Azulay, J. Pouget, S. Attarian, 2005, Clinical Neurophysiology.

Triple‐stimulation technique improves the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy

A. Trébuchon, J. Pouget, Y. Duclos, 2015, Muscle & nerve.

Prevalence, correlates and impact of pain and cramps in anti‐MAG neuropathy: a multicentre European study

J. Cassereau, S. Attarian, E. Delmont, 2018, European journal of neurology.

Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen‐specific glycopolymer

T. Derfuss, A. Steck, B. Ernst, 2020, Journal of neurochemistry.

Objective Evaluation of Clinical Actionability for Genes Involved in Myopathies: 63 Genes with a Medical Value for Patient Care

M. Cossée, N. Lévy, J. Rendu, 2022, medRxiv.

HEREDITARY INCLUSION-BODY MYOPATHY ASSOCIATED WITH CARDIOMYOPATHY: REPORT OF TWO SIBLINGS

J. Pouget, P. Cintas, J. Azulay, 2010 .

Fibromyalgia‐like symptoms associated with irritable bowel syndrome: A challenging diagnosis of late‐onset Pompe disease

J. Pouget, S. Attarian, E. Salort-Campana, 2015, Muscle & nerve.

[Diagnosis of vitamin B12 deficiency: a case illustrating diagnostic pitfalls].

J. Pouget, L. Chiche, J. Franques, 2010, Revue neurologique.

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

J. Statland, M. Pasnoor, J. Verschuuren, 2021, The Lancet Neurology.

Multidisciplinary rehabilitation is relevant in severe myasthenia gravis: an observation.

S. Attarian, A. Verschueren, L. Bensoussan, 2021, Annals of physical and rehabilitation medicine.

Volume 14, Issue 2, Spring 2015 Editorial in Charge

S. Akhondzadeh, M. Harirchian, F. Fatehi, 2015 .

Facioscapulohumeral dystrophy weakened sarcomeric contractility is mimicked in induced pluripotent stem cells‐derived innervated muscle fibres

F. Magdinier, S. Attarian, E. Novoa-Del-Toro, 2021, Journal of cachexia, sarcopenia and muscle.

Convergence of patient- and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy

F. Rivier, C. Béroud, F. Chapon, 2022, Orphanet Journal of Rare Diseases.

[Marseille welcomes the FSHD Society International Research Conference].

F. Magdinier, S. Attarian, K. Nguyen, 2019, Medecine sciences : M/S.

Commentary: Long-Term Exercise Reduces Formation of Tubular Aggregates and Promotes Maintenance of Ca2+ Entry Units in Aged Muscle

N. Lévy, M. Bartoli, S. Attarian, 2021, Frontiers in Physiology.

Further heterogeneity in myopathy with tubular aggregates?

D. Figarella-Branger, J. Pouget, N. Lévy, 2012, Muscle & nerve.

Motor unit number index correlates with disability in Charcot-Marie-Tooth disease

J. Pouget, F. Fatehi, M. Lefebvre, 2018, Clinical Neurophysiology.

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

I. Chumakov, J. Pouget, Serguei Nabirotchkin, 2014, Orphanet Journal of Rare Diseases.

Peripheral nerve involvement in Fabry's disease: Which investigations? A case series and review of the literature.

J. Pouget, B. Dussol, J. Franques, 2017, Revue neurologique.

Novel Electromyographic Monitoring Technique for Prevention of Right Phrenic Nerve Palsy During Cryoballoon Ablation

J. Deharo, F. Franceschi, L. Koutbi, 2013, Circulation. Arrhythmia and electrophysiology.

Quantitative multiplex PCR of short fluorescent fragments for the detection of large intragenic POLG rearrangements in a large French cohort

C. Richelme, J. Pouget, A. Chaussenot, 2013, European Journal of Human Genetics.

Immunoglobulin shortage: Practice modifications and clinical outcomes in a reference centre.

A. Grapperon, S. Attarian, A. Verschueren, 2021, Revue neurologique.

Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15

E. Marchioni, L. Benedetti, J. Devaux, 2017, Journal of Neuroinflammation.

Motor-evoked potential gain is a helpful test for the detection of corticospinal tract dysfunction in amyotrophic lateral sclerosis

J. Pouget, E. Jouve, Y. Duclos, 2017, Clinical Neurophysiology.

Association between structural and functional corticospinal involvement in amyotrophic lateral sclerosis assessed by diffusion tensor MRI and triple stimulation technique

A. Loundou, J. Ranjeva, S. Confort-Gouny, 2014, Muscle & nerve.

Magnetic stimulation including the triple‐stimulation technique in amyotrophic lateral sclerosis

J. Pouget, S. Attarian, A. Verschueren, 2007, Muscle & nerve.

Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011.

A. Béhin, S. Attarian, E. Salort-Campana, 2012, Revue neurologique.

Myositis in infiltrative lymphocytosis syndrome: clinicopathological observations and treatment

J. Pouget, A. Donnet, S. Attarian, 2004, Neuromuscular Disorders.

New multiplex PCR-based protocol allowing indirect diagnosis of FSHD on single cells: can PGD be offered despite high risk of recombination?

M. Barat‐Houari, F. Vasseur, J. Pouget, 2010, European Journal of Human Genetics.

Fat fraction distribution in lower limb muscles of patients with CMT1A

Augustin C. Ogier, M. Guye, M. Lefebvre, 2020, Neurology.

254th ENMC international workshop. Formation of a European network to initiate a European data collection, along with development and sharing of treatment guidelines for adult SMA patients. Virtual meeting 28 – 30 January 2022

E. Mercuri, B. Bartels, H. Lochmüller, 2023, Neuromuscular Disorders.

Is muscle spindle proprioceptive function spared in muscular dystrophies? A muscle tendon vibration study

Jean-Marc Aimonetti, Shahram Attarian, Edith Ribot-Ciscar, 2004, Muscle & nerve.

A motor cortex excitability and gait analysis on Parkinsonian patients

Shahram Attarian, Marianne Vaugoyeau, J. Azulay, 2010, Movement disorders : official journal of the Movement Disorder Society.

Excitability of the lower-limb area of the motor cortex in Parkinson's disease

A. Eusebio, J. Azulay, S. Attarian, 2010, Neurophysiologie Clinique/Clinical Neurophysiology.

Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation

A. Eusebio, T. Witjas, J. Azulay, 2007, Clinical Neurophysiology.

CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome

H. Kramers, G. Marfia, T. Feasby, 2023, Neurology.

Rapid identification of mitochondrial DNA (mtDNA) mutations in neuromuscular disorders by using surveyor strategy.

D. Wallace, J. Gargus, P. Calvas, 2008, Mitochondrion.

Functional impact of vibratory proprioceptive assistance in patients with facioscapulohumeral muscular dystrophy

Jean-Marc Aimonetti, Shahram Attarian, Edith Ribot-Ciscar, 2015, Muscle & nerve.

Visualization of Gray Matter Atrophy and Anterior Corticospinal Tract Signal Hyperintensity in Amyotrophic Lateral Sclerosis Using 7T MRI

M. Guye, V. Callot, Aurélien Massire, 2021, Neurology.

Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks

Y. Chien, B. Schoser, S. Illarioshkin, 2023, JAMA neurology.

Prospective clinical and electrophysiological follow-up on a multiple sclerosis population treated with interferon beta-1 a

J. Pouget, J. Pelletier, S. Attarian, 2007, Multiple sclerosis.

Identification of novel pathogenic copy number variations in Charcot-Marie-Tooth disease

C. Béroud, J. Desvignes, N. Lévy, 2019, Journal of Human Genetics.

Deep phenotyping of an international series of patients with late‐onset dysferlinopathy

G. Bassez, T. Maisonobe, F. Leturcq, 2021, European journal of neurology.

A New Point Mutation in the PMP22 Gene in a Family Suffering From Atypical HNPP.

N. Lévy, S. Attarian, E. Delmont, 2020, Journal of neuromuscular diseases.

Validation of ELISA assays for the calculation of FLC indices for the diagnosis of intrathecal immunoglobulin synthesis

J. Mege, L. Koric, S. Attarian, 2023, Clinical chemistry and laboratory medicine.

Prevalence of spasticity and spasticity-related pain among patients with Amyotrophic Lateral Sclerosis.

S. Attarian, A. Verschueren, E. Delmont, 2021, Revue neurologique.

Global motor unit number index sum score for assessing the loss of lower motor neurons in amyotrophic lateral sclerosis

A. Grapperon, S. Attarian, A. Verschueren, 2017, Muscle & nerve.

Motor unit number index as an individual biomarker: Reference limits of intra-individual variability over time in healthy subjects

J. Lefaucheur, Y. Péréon, P. Cintas, 2020, Clinical Neurophysiology.

Covariation of corticospinal efficiency and silent period in motoneuron diseases

A. Schmied, J. Pouget, S. Attarian, 2006, Muscle & nerve.

Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?

J. Pouget, A. Grapperon, S. Attarian, 2016, Clinical Neurophysiology.

[Chronic inflammatory demyelinating polyradiculoneuropathy].

J. Azulay, J. Pouget, J. Franques, 2010, La Revue de medecine interne.

Enhancement of single motor unit inhibitory responses to transcranial magnetic stimulation in amyotrophic lateral sclerosis

A. Schmied, S. Attarian, 2008, Experimental Brain Research.

New strategy for improving the diagnostic sensitivity of repetitive nerve stimulation in myasthenia gravis

J. Pouget, J. Franques, A. Grapperon, 2017, Muscle & nerve.

Motor cortical reorganization is present after a single attack of multiple sclerosis devoid of cortico-spinal dysfunction

J. Ranjeva, S. Confort-Gouny, P. Cozzone, 2011, Magnetic Resonance Materials in Physics, Biology and Medicine.

Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

I. Chumakov, J. Pouget, Serguei Nabirotchkin, 2016, Orphanet Journal of Rare Diseases.

Dysferlinopathy in Iran: Clinical and genetic report

N. Lévy, F. Fatehi, M. Krahn, 2015, Journal of the Neurological Sciences.

Assessing the upper motor neuron in amyotrophic lateral sclerosis using the triple stimulation technique: A multicenter prospective study

F. Salachas, D. Devos, Anne‐Sophie Rolland, 2021, Clinical Neurophysiology.

Changes in cortically induced inhibition in amyotrophic lateral sclerosis with time

A. Schmied, J. Pouget, S. Attarian, 2009, Muscle & nerve.

[Research in amyotrophic lateral sclerosis: what is new in 2009?].

T. Perez, A. Echaniz-Laguna, P. Cintas, 2010, Revue neurologique (Paris).

[Lambert-Eaton myastenic syndrome revealing neuroblastoma in 2 children].

E. Bosdure, B. Chabrol, S. Attarian, 2006, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease.

A. Echaniz-Laguna, Y. Péréon, P. Latour, 2023, European journal of neurology.

Motor evoked potentials in clinically isolated syndrome suggestive of multiple sclerosis

A. Eusebio, J. Pouget, J. Franques, 2009, Multiple sclerosis.

Cortical versus spinal dysfunction in amyotrophic lateral sclerosis

J. Vedel, A. Schmied, J. Pouget, 2006, Muscle & nerve.

“Everything is hard before it’s easy” – Thomas Fuller

S. Attarian, 2011, Clinical Neurophysiology.

A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients

D. Commenges, O. Blin, Daniel Cohen, 2017, PloS one.

A meta-analysis of randomized double-blind clinical trials in CMT1A to assess the change from baseline in CMTNS and ONLS scales after one year of treatment

I. Chumakov, Daniel Cohen, J. Micallef, 2015, Orphanet Journal of Rare Diseases.

Expanding the spectrum of VEXAS syndrome: association with acute-onset CIDP

B. Faucher, M. Ebbo, S. Attarian, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

Ulnar neuropathy at the elbow: Reappraisal of the wrist-upper arm latency difference between ulnar and median nerves

L. Tatu, T. Kuntzer, A. Grapperon, 2019, Clinical Neurophysiology.

Progression of cortical and spinal dysfunctions over time in amyotrophic lateral sclerosis

J. Vedel, A. Schmied, J. Pouget, 2008, Muscle & nerve.

Quantitative muscle MRI study of patients with sporadic inclusion body myositis

Augustin C. Ogier, M. Guye, A. Grapperon, 2020 .

The Impact of Fatty Infiltration on MRI Segmentation of Lower Limb Muscles in Neuromuscular Diseases: A Comparative Study of Deep Learning Approaches.

Augustin C. Ogier, M. Guye, Y. le Fur, 2023, Journal of magnetic resonance imaging : JMRI.

P. Latour, T. Stojkovic, A. Nadaj-Pakleza, 2023, European journal of neurology.

Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Author's reply

J. Pouget, J. Azulay, S. Attarian, 2007 .

[Myasthenia gravis and chronic lymphocytic leukemia: a lucky association?].

J. Pouget, J. Azulay, P. Disdier, 2001, La Revue de medecine interne.

Estimation of subvoxel fat infiltration in neurodegenerative muscle disorders using quantitative multi‐T2 analysis

H. Greenspan, T. Blumenfeld‐Katzir, Y. le Fur, 2023, NMR in biomedicine.

Myofibrillar myopathies: State of the art, present and future challenges.

I. Nelson, D. Figarella-Branger, N. Romero, 2015, Revue neurologique (Paris).

[Lower motor neuron disease and signs of dysimmunity].

J. Pouget, J. Azulay, S. Attarian, 2000, Revue neurologique (Paris).

Refining NGS diagnosis of muscular disorders

N. Lévy, S. Gorokhova, M. Bartoli, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Innovation in characterizing cardiac autonomic neuropathy using supervised learning

S. Attarian, 2023, Clinical Neurophysiology.

Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients

Y. Chien, B. Schoser, S. Illarioshkin, 2021 .

Microinfusion of the Metabotropic Glutamate Receptor Agonist 1S, 3R–1‐Aminocyclopentane‐1, 3‐dicarboxylic Acid Into the Nucleus Accumbens Induces Dopamine‐dependent Locomotor Activation in the Rat

M. Amalric, S. Attarian, Shahram Attarian, 1997, The European journal of neuroscience.

Identification of variants in the 4 q 35 gene FAT 1 in patients with a Facioscapulohumeral dystrophy ( FSHD )-like phenotype

F. Puppo, Y. Hayashi, I. Nishino, 2015 .

[Proximal myotonial myopathy (PROMM): clinical and histology study].

G. Bassez, J. Pouget, P. Laforêt, 2001, Revue neurologique.

Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

Karla P. Zepeda, Hansie M Mathelier, J. Felius, 2023, Neurology and Therapy.

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

M. Sweetser, Y. Parman, P. Dyck, 2018, The New England journal of medicine.

Myofibrillar myopathies: State of the art, present and future challenges.

I. Nelson, D. Figarella-Branger, N. Romero, 2015, Revue neurologique.

Towards the molecular elucidation of congenital myasthenic syndromes: identification of mutations in MuSK.

C. Legay, L. Schaeffer, E. Goillot, 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis

F. Salachas, D. Devos, J. Duce, 2020, Journal of Neural Transmission.

Association between brain and upper cervical spinal cord atrophy assessed by MRI and disease aggressiveness in amyotrophic lateral sclerosis

J. Ranjeva, M. Guye, S. Attarian, 2023, Neuroradiology.

Impact of a frequent nearsplice SOD1 variant in Amyotrophic Lateral Sclerosis: optimizing SOD1 genetic screening for gene therapy opportunities

F. Salachas, M. Amador, C. Cazeneuve, 2022 .

Impact of a frequent nearsplice SOD1 variant in Amyotrophic Lateral Sclerosis: optimizing SOD1 genetic screening for gene therapy opportunities

F. Salachas, M. Amador, C. Cazeneuve, 2022 .

Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses

P. Latour, S. Attarian, D. Adams, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Detection of proximal conduction blocks using a triple stimulation technique improves the early diagnosis of Guillain–Barré syndrome

S. Attarian, E. Delmont, E. S. Campana, 2018, Clinical Neurophysiology.